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Background: The role of the microenvironment during the initiation and progression of carcinogenesis is thought
to be of critical importance, both for the enhanced understanding of fundamental cancer biology as well as for
improving molecular diagnostics and therapeutics. The aim of this study was to establish an in vitro model based
on a co-culture of healthy human fibroblasts (HFs) and human osteosarcoma cells (MG-63s) to simulate the
microenvironment including tumor and healthy cells.
Methods: The HFs and MG-63s were in vitro co-cultured for a period of time ranging from 24 h to 7 days. Cell
morphology and organization were studied using phase contrast microscopy while the expression of Human
Cartilage Glycoprotein 39 (YKL-40), Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloprotease 1 (MMP1)
was investigated by Real Time PCR and Western Blotting.
Results: The results showed a characteristic disposition of tumor and healthy co-cultured cells in columns which
are not visible in tumor and healthy cells grown singularly. The expression of YKL-40, VEGF and MMP1 significantly
changed in co-cultured cells compared to HFs and MG-63s separately cultured.
Conclusions: We concluded that the tumor microenvironment has an influence on the protein expression of the
healthy surrounding tissues and the process of tumorigenicity.
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Human fibroblast cellsBackground
In normal tissue, cells communicate through a complex
network of interactions: physically, through direct contact
or through the intervening extracellular matrix (ECM),
and biochemically, through both soluble and insoluble
signaling molecules [1]. Under persistent inflammatory
conditions, the continual upregulation of enzymes, such as
matrix metalloproteinases (MMPs) by stromal fibroblasts
can disrupt the ECM; furthermore, invading immune cells
can overproduce factors which promote abnormal gene ex-
pression [1]. These conditions are normally reversible but,
when inflammation is sustained, the normal organization
of cells might lead to gene expression instability within
the healthy cells and the acquisition of tumorigenic po-
tential [2]. These chronic inflammatory conditions help to* Correspondence: mirella.falconi@unibo.it
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unless otherwise stated.establish a tumor microenvironment full of deranged pro-
liferative signaling networks, which is largely orchestrated
by inflammatory cells [3].
A tumor microenviroment includes invasive cancer
cells and stromal cells, consisting in cancer-associated
non-malignant fibroblasts, which provide an essential
communication network via secretion of growth factors
and chemokines. This condition leads to an altered ECM
and provides additional oncogenic signals enhancing
cancer-cell proliferation and invasion [4]. While the stro-
mal cells are not malignant per se, their role in support-
ing cancer growth and development is vital to the
survival of the tumor [5,6].
The aim of the study was to establish an in vitro model
based on the co-culture of healthy human fibroblasts
(HFs) and human osteosarcoma cells (MG-63s) to simulate
the microenvironment of healthy tissue in connection with
cancer cells. The final goal was to analyze the influence ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gating the gene and protein expression of some biomarkers
involved in cancer progression and invasion. A better un-
derstanding of the molecular mechanisms in the tumor
microenvironment could be a crucial key to improving
anti-cancer therapy.
During the past decade, there has been growing inter-
est regarding glycoprotein YKL-40 [7,8], also known as
chitinase 3–like 1 (CHI3L1) [9] and as human cartilage
glycoprotein–39 (HC-gp39) [10]. YKL-40 is involved in
angiogenesis [11] and the upregulation of the vascular
endothelial growth factor expression (VEGF) in several
cell lines [12-14]. Furthermore, YKL-40 plays a role in
inflammation and tissue remodeling [15,16]. The aberrant
and elevated expression of YKL-40 is largely associated
with the pathogenesis of a variety of human diseases, such
as rheumatoid- and osteoarthritis, hepatic fibrosis and
asthma, which is connected to its pathological function
and is associated with extracellular matrix remodeling,
suggesting that the serum levels of YKL-40 serve as a
diagnostic and prognostic biomarker [7].
Tumor invasion is also characterized by the increased
ability of tumor cells to degrade ECM components
through an enhanced expression of proteases, including
matrix metalloproteinases secreted or anchored to the cell
membrane. Among the membrane-type MMPs, matrix
metalloproteinases 1 (MMP1) has been particularly impli-
cated in pericellular proteolysis associated with cell migra-
tion and invasion [17]. An overexpression of MMP1 has
been described in many types of human tumor tissues
[18]. In addition, several studies have reported that MMP1
is produced by invasive tumor cells in vivo as well as
in vitro and is thus associated with vascular remodeling,
angiogenesis and tumor progression [17].
Acting together with metalloproteinases, the VEGF is
a key regulator of physiological angiogenesis during
embryogenesis, in vascular remodeling, wound healing,
cell invasion, permeability, proliferation and survival [19].
The VEGF has also been implicated in pathological angio-
genesis associated with tumors, intraocular neovascular
disorders and other conditions. Inhibition of the VEGF is
also being tested as a strategy for the prevention of angio-
genesis and vascular leakage in several pathological condi-
tions [20].
In the present study, we tested the expression of YKL-
40, VEGF and MMP-1 in HFs and MG-63s seeded both
alone and mixed in a co-culture system, for a period of
time ranging from 24 h to 96 h. Light phase contrast mi-
croscopy was carried out to study the organization and
orientation of cells in the co-culture from 4 to 7 days.
The influence of direct contact between the tumor cells
and the non-malignant cells, and the interconnections of
the biomarkers investigated and their role in tumor inva-
sion and matrix remodeling were discussed.Results
Morphological analysis by phase contrast microscopy
After 4 days of co-culture, the MG-63s and the HFs
showed a specific and characteristic organization based
on cord-like formations (Figure 1A). After 7 days of co-
culture, the cord-like formations were larger and the
HFs were almost completely covered by MG-63 cells
(Figure 1B).
On the contrary, control samples of the MG-63s and
the HFs, grown separately, showed their characteristic
cell morphology. The MG-63s had a polygonal morph-
ology after 24 h of culture (Figure 1C) while the HFs
showed a fibroblastic morphology with an elongated cell
body after 24 h of culture (Figure 1D). At the end of
7 days of culture, both HFs and MG-63s had reached
confluence (Figure 1E and F).
qRT-PCR of YKL-40 and VEGF in co-cultured HFs and
MG-63 cells
To examine changes in protein expression during the
coexistence of HFs and MG-63 cells, the mRNA expres-
sion of YKL-40 and VEGF was evaluated using a quanti-
tative real time polymerase chain reaction (qRT-PCR) in
cells grown in co-culture, and the results were compared
to the same cells grown separately as controls.
The expression of YKL-40 in HF cells seeded separately
and used as controls was almost absent. Indeed, YKL-40
expression was the highest at 24 h; it subsequently de-
creased and remained constant up to 96 h (Figure 2). In
MG-63 cells, the expression of YKL-40 was very high at
24 h in controls seeded separately and then decreased until
96 h. In the MG-63 cells grown in co-culture, a similar
trend to the HFs grown in co-culture was observed, but
with a slightly lower intensity of expression (Figure 2).
The VEGF showed constant expression in the HFs both
grown in co-culture and separately while, in MG-63 cells,
it was higher in co-culture with respect to the control cells
seeded separately (Figure 3).
Western Blotting and densitometric analysis
Control HFs showed a low level of MMP1 expression
after 24 h of culture while it increased after 96 h. On the
contrary, MG-63 control cells demonstrated a higher ex-
pression of MMP1 protein after 24 h and 96 h of culture
as compared to HFs (Figure 4A).
In the co-cultured cells, the intensity of the MMP1
bands increased considerably over time, reaching the
highest intensity in HFs at 72 h and in MG-63s at 48 h
(Figures 4A and B), as demonstrated by densitometric
analysis (Figure 4C).
Discussion
For many years, laboratories have sought to under-
stand the mechanisms by which cells respond to their
Figure 1 Phase contrast microscopy. (A) Co-culture of MG-63 cells and HFs grown for 4 days. Cord-like formations are well detected (*). HFs
worked as a climbing frame on which the MG-63 cells (arrow) adhered and proliferated. Single HFs were also observed (arrowhead). (B) phase
contrast microscopy of the co-culture of MG-63 cells and HFs grown for 7 days. Thicker cord-like formations were detected (*). (C) phase contrast
microscopy of the co-culture of MG-63 cells grown separately in monolayers for 24 h. (D) phase contrast microscopy of HFs grown in monolayers
for 24 h. (E) phase contrast microscopy of MG-63 cells grown in monolayers for 7 days. (F) phase contrast microscopy of HFs grown in monolayers for
7 days. Magnification for all the images was 100X. Aperture number is 0.25.
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to specify programs of gene expression and, ultimately,
tissue phenotype. Understanding these processes and
their alteration will engender a greater appreciation of the
mechanisms involved in tumor progression.
The scientific literature has shown how remodeling
the ECM and producing aberrations can stimulate the
development of cancer [21].
The aim of the present study was to develop an in vitro
methodology for investigating the interactions between
non-malignant cells and tumor cells, and to verify how the
microenvironment influences cells in the co-culture system.
During malignant transformation, healthy and tumor cells
are increasingly described as networks of their physicaland signaling contacts [22]; with this network analysis
approach, we chose to co-culture a healthy and non-
malignant population of human fibroblast cells with a
human osteosarcoma cell line, MG-63s, to study the
morphological and molecular changes originated by
this direct interaction.
The morphological analysis of cells independently co-
cultured in monolayers demonstrated a well-defined and
different cell morphology of MG-63s and HFs in contrast
to monolayers of co-cultured HFs and MG-63s which
showed cord-like structures after 4 days of culture, thick-
ening after 7 days. We suggested that, in cord-like struc-
tures, the fibroblasts worked as a climbing frame on which
the MG-63 cells adhered and proliferated. The absence of
Figure 2 Real Time PCR for YKL-40. Expression of HFs and MG-63 cells independently grown and co-cultured. *represents a significant difference
from the MG-63 control cells, P < 0.05.
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separately suggests a morphological rearrangement due to
modifications in the microenvironment of the co-culture
system. Fauquette and colleagues [23] demonstrated that
the cord-like morphogenesis was supported by changes in
the cell surface receptor after contact between tumor cells
and healthy cells, which was eventually associated with an
elevated expression of adhesive molecules, leading to cell
contact reorganization and cell-matrix changes. These dataFigure 3 Real Time PCR for VEGF. Expression of HFs and MG-63 cells ind
from the HF control sample at 24 h, P < 0.05. # represents a significant diffecorrelated well with our results and with tumor invasive-
ness ability.
To verify whether the microenvironment has an influ-
ence on cells grown in co-culture, the expression of the
YKL-40, VEGF and MMP1 proteins involved in the pro-
gression of pathological conditions was analyzed. Some
years ago, Johansen et al. [24] identified a protein called
YKL-40, secreted in vitro in several types of solid tumors
and in large amounts by MG-63 cells. On the contrary,ependently grown and co-cultured. *represents a significant difference
rence from the MG-63 control cells at 24 h, P < 0.05.
Figure 4 Western Blot for MMP1. (A) MMP1 expression of HFs and MG-63 cells independently grown and (B) co-cultured. (C) Densitometric
analysis of MMP1 expression relative to HFs and MG-63 cells independently grown and co-cultured. *represents a significant difference from the
HF control sample, P < 0.05. # represents a significant difference from the MG-63 control cells, P < 0.05.
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in HFs [16]. For this reason, we have chosen the YKL-40
protein as the main marker for verifying the influence of
tumor cells grown in contact with healthy cells.
As reported in the literature [25], YKL-40 was identified
as a tumor angiogenesis factor, inducing coordination of
membrane-bound receptor syndecan 1 and integrin αvβ3,
and activating an intracellular signaling cascade includ-
ing FAK (focal adhesion kinase), Erk 1, and Erk 2 [26].
Furthermore, YKL-40 not only increased the expression
of Flk-1/KDR (phosphatidylinositol 3-kinase/akt signal),
VEGF receptor 2 which mediates VEGF angiogenesis [27],
but also activated the tyrosine phosphorylated form of
Flk-1/KDR, possibly leading to a synergistic effect on an-
giogenic signaling activation. YKL-40 purified from the
MG-63 osteosarcoma cell line has growth factor activity
for fibroblast cell lines [15]. The YKL-40 secreted by can-
cer cells has a role in the mutation of the fibroblasts sur-
rounding the tumor, including the activation of fibroblast
morphologic transformation, secretion of MMPs and neo-
vascularization. Therefore, YLK-40 promotes the prolif-
eration, differentiation and invasion of cancer cells and
the destruction of stroma [28-30]. The overexpression of
MMP1 has been shown in tumor tissues and has been
suggested to be associated with tumor invasion andmetastasis [18]. The production of MMP1 is stimulated in
fibroblasts by growth factors and cytokines; it is postulated
that YKL-40 acts synergistically as a growth factor with
VEGF, stimulating MMP1 expression [13,19].
Starting from these previous data, we investigated the
expression of YKL-40, the VEGF and MMP1 using Real
Time PCR and Western Blotting, first in cells grown
separately and then in the co-culture system, in order to
compare the protein expression trend in both cellular
groups. The final goal was to verify whether HFs under-
went changes after direct contact with tumoral cells.
Real Time results demonstrated that YKL-40 was
expressed only in MG-63 control cells, in accordance
with the literature [16], and was not expressed in HF
control cells, during the entire experimental time. In
addition, our data gave an unexpected result; in the co-
culture system, we found the expression of YKL-40 even
in HFs, although fibroblasts do not normally express this
protein in vitro. The HFs co-cultured with MG-63s ef-
fectively showed an elevated expression of YKL-40 after
24 h, and then remained almost constant during the
experiment.
The expression of the VEGF is quite constant in the
HFs used as controls and in co-cultures, but increases in
MG-63 cells when co-cultured. We suggest that the
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YKL-40 expression in HFs, and on VEGF expression in
MG-63 cells, perhaps due to the growth factor activity of
YKL-40 secreted in the tumor cell-conditioned medium
and to its direct role in stimulating VEGF expression and
ECM remodeling.
Western Blot analyses showed weak MMP1 expression
in control HFs and a more elevated expression in con-
trol MG-63 cells. In both samples, the level of MMP1
gradually increased during the time of culture. Co-
cultures of HFs and MG-63 cells showed high levels of
MMP1 after only 24 h and they greatly increased up to
96 h, suggesting a strong influence of the tumor micro-
enviroment on the upregulation of the matrix metallo-
proteinases responsible for the disruption of the ECM
and tumor invasiveness [2]. In consideration of our re-
sults, we could better postulate the role of YKL-40 in the
tumor microenvironment.
Ngrnyuang et al. have recently reported [14] that the
effects of YKL-40 are cell type-dependent, probably due
to the different biochemical composition between cell
lines. Human fibroblasts and MG-63s represent two bio-
logically different cellular types involved in parallel roles
during tumor progression. Tumor cells, releasing pro-
inflammatory factors, are able to induce the activity of
NF-kB (Nuclear Factor kappa B) in fibroblast cells which,
in turn, induce the release of growth factors and cytokines
in the adjacent extracellular matrix, enhancing an inflam-
matory microenvironment and promoting changes in the
ECM. Our hypothesis is that YKL-40 may have synergistic
effects; on HFs, it can act similarly to insulin-like growth
factor-1, leading to an inflammatory condition and pro-
moting an up-regulation in MMP-1 expression, in order
to remodel the extracellular matrix. In addition to the in-
flammatory conditions, the expression of YKL-40 in MG-
63s, correlated with those of the VEGF, suggests that
YKL-40 acts as an angiogenic factor in tumor cells, as has
been reported in the literature.
Following these preliminary data, it could be of great
interest to examine the effect of the siRNA knockdown
of YKL-40 in MG-63 cells on the changes reported in
protein expression in the co-cultures. These experiments
are currently in progress.
Conclusions
In conclusion, this study showed that cancer evolution
can involve changes in the microenvironment as a result
of oncogenic stress within healthy cells. The phenotypic
reorganization between fibroblasts and MG-63 cells, extra-
cellular matrix remodeling, changes in YLK-40 protein ex-
pression and increased VEGF expression are indications of
cancer progression.
Our experimental approach suggested a realistic in vitro
model of the tumor microenvironment, useful for betterinvestigating the complex mechanisms which transform a
healthy tissue environment to a malignant state.
Methods
Primary culture of HFs
Human dental ligament (HDL) tissues were collected
from the mid-third of roots of teeth extracted for ortho-
dontic reasons, following informed consent of the pa-
tients. After several washes in PBS, the HDL tissues were
cut into small pieces and placed into culture dishes with
1 mL of Dulbecco’s Modified Essential Medium (DMEM)
(Invitrogen, Carlsbad, CA, USA) supplemented with 10%
(v/v) fetal bovine serum (FBS), penicillin (100 mg/mL) and
streptomycin (10 mg/mL). The culture medium was chan-
ged twice a week. When the HFs were subconfluent
(70–80%) they were scraped off using 0.05% trypsin/
EDTA (Gibco, Grand Island, NE), washed and placed into
T75 flasks. The cells obtained were cultured at 37°C in a
humidified atmosphere of 5% CO2. Cells from passages 3
to 10 were utilized for the following experiments.
MG-63 cell culture
The MG-63 cell line was purchased from ATCC® CRL-
1427™ (USA) and cultivated in DMEM (Invitrogen,
Carlsbad, CA, USA) containing 10% FBS, supplemented
with 10% (v/v) FBS, penicillin (100 mg/mL) and strepto-
mycin (10 mg/mL) according to the recommendation of
the supplier. The cells were cultured in T25 flasks (Nunc,
USA) in a humidified incubator at 37°C in a 5% CO2 hu-
midified atmosphere. For passaging, the cells were de-
tached with trypsin/EDTA and subsequently replated.
Co-cultures of HFs and MG-63 cells
The HFs and the MG-63 cells were seeded at the same
density (15 × 103 cells/mL each) in T75 flasks and cul-
tured in DMEM F-12 supplemented with 10% (v/v) FBS,
penicillin (100 mg/mL) and streptomycin (10 mg/mL)
for 24 h, 48 h, 72 h and 96 h.
As controls, monocultures of MG-63 cells and HFs
were seeded separately in T75 flasks and were cultured
under the same conditions as the co-cultures. The cell
medium was replaced twice a week.
Monostrate cultures and morphological analysis using
phase contrast microscopy
Ten ×103 cells/ml were seeded on glass slides in 6 multi-
wells and co-cultured for 4 and 7 days. At the end of each
experimental time point, the samples were observed using
a phase contrast microscope Motic AE21. The images
were recorded using Visicam 3.0 and analyzed by VisiCam
Image Analyzer software, version 6.1.3.3.
The images of Figure 1 were representative for three
independent experiments.
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At every experimental time point, the cells seeded in co-
cultures were detached, collected and counted for separ-
ation with MS Columns and Anti-Fibroblast Microbeads
System (MACS, Miltenyi Biotec) according to the manu-
facturer’s instructions. Briefly, the cells were centrifuged,
and the pellets were suspended in MACS buffer solu-
tion. The HFs were then magnetically labeled with hu-
man Anti-Fibroblast MicroBeads while the unlabeled
MG-63s were run through the column after 3 washes with
MACS buffer. By so doing, the MG-63 fraction was de-
pleted of HFs. After removing the column from the mag-
netic field, the magnetically retained HFs were eluted as
the positively-selected cell fraction. The separation effi-
ciency guaranteed by the MACS Miltenyi System was
more than 90%.
RNA extraction
Total RNA from control and co-cultured pellets was
extracted using Nucleospin RNA II (Macherey-Nagel)
and quantified using a NanoDrop® ND-1000 UV–vis
Spectrophotometer (Thermo Scientific, Wilmington, DE,
USA). One μg of total RNA was reverse transcribed using
a high capacity cDNA Reverse Transcription kit (Applied
Biosystem, Life Technologies, Monza Italy) according to
the manufacturer’s instructions.
Real time PCR
The expression of mRNA was analyzed by quantitative
Real Time PCR using 7500 Real Time PCR (Applied
Biosystem, Life Technologies, Monza, Italy). All reactions
were carried out in a 25 μL reaction volume in triplicate.
For the analysis, the following TaqMan assays (Applied
Biosystems, Life Technologies, Monza, Italy) were used:
Hs00609691_m1 for YKL-40 and Hs00900055_m1 for
VGEF. All samples were normalized to glyceraldehyde 3-
phosphate dehydrogenase (GAPDH, Hs99999905_m1)
expression.
The data were representative of three independent ex-
periments and showed the average of triplicates ± SD.
Western blot analysis and densitometric analysis
At each experimental time point, the cell pellets were lysed
for 30 minutes using a RIPA extraction buffer (Invitrogen,
Life Technologies, Monza Italy) supplemented with a pro-
tease inhibitor cocktail (Sigma Aldrich, St Louis, Missouri,
USA), 1 mM PMSF and 0.15% β-mercaptoethanol (Fluka,
Sigma Aldrick, St Louis, Missouri, USA). The samples
were centrifuged at 14,000 rpm for 10 minutes at 4°C, and
the total protein amounts were assayed using Bradford re-
agent (Sigma Aldrich, St. Louis, Missouri, USA).
Twenty μg of total protein were resolved on NuPAGE®
SDS-PAGE pre-cast gels (4-12%) (Invitrogen, Life Tech-
nologies, Monza, Italy), and the protein was transferredto a nitrocellulose membrane (GE Healthcare Europe
GmbH, Milan, Italy), blocked with no fat dry milk
(Sigma Aldrich, St. Louis, Missouri, USA) for 30 min at
room temperature (RT), and immunolabeled with anti-
MMP1 1:500 in TBS pH7.5 and anti-β tubulin 1:10000
in TBS pH7.5 overnight at 4°C. The bands were visual-
ized using an ECL Advanced TM Western blotting de-
tection kit (GE Healthcare Europe GmbH, Milan, Italy)
and the images were recorded with a Kodak digital image
station (Eastman Kodak, Rochester, NY, USA).
Band densitometry was measured using Image J soft-
ware (National Institutes of Health) and the intensities
of the specific protein bands were corrected for equal β-
tubulin loading; they were expressed as relative to the
intensity of the control sample. The relative quantitation
of the western blots was expressed relative to the β-
tubulin present on each blot.
The images of Figure 4 were representative of three in-
dependent experiments. The densitometry data were
representative of three independent experiments and
showed the average of triplicates ± SD.
Statistical analysis
The statistical analysis was carried out using GRAPH
PAD PRISM 5.0 software (San Diego, CA) by applying
ANOVA and the Dunnet’s multiple comparison test.
The differences were considered significant at p < 0.05.
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